NASDAQ:ARGX

ARGX Stock Watch: Argenx Up Ahead of Immunovant Trial Data
······

ARGX Stock Watch: Argenx Up Ahead of Immunovant Trial Data

argenx SE shares rose 0.7% to $803.67 Wednesday, trailing biotech peers after Immunovant reported positive rheumatoid arthritis trial data for IMVT-1402, sending its stock up 35.1%. VYVGART sales reached $1.3 billion last quarter. The FDA recently expanded VYVGART’s approval for generalized myasthenia gravis. argenx’s next key data releases are expected later this year.
May 20, 2026

Stock Market Today

  • Global X Semiconductor ETF Surges 148% on AI, EV and Tech Demand
    May 29, 2026, 9:10 PM EDT. The Global X Semiconductor ETF (ASX: SEMI) has surged 148% over the past 12 months, driven by rising demand for chips essential to AI, cloud computing, electric vehicles and more. The ETF tracks 30 top global semiconductor firms, including Nvidia, Taiwan Semiconductor Manufacturing, ASML and Broadcom, which supply critical technology for AI systems and advanced manufacturing. Semiconductors act as the 'brains' powering modern devices, vital for AI training and automation. Analysts say growth catalysts are likely to persist as AI adoption expands and digital infrastructure strengthens. The ETF offers diversified exposure across the global semiconductor supply chain, making it a compelling option for investors seeking access to this strategic sector.